Which biopharma positions are hardest to fill? What skills are most in demand? And what can companies do to ensure they discover and nurture talent?

The collective viewpoints and challenges of CDMOs have been overlooked once too often. PBOA was born to give them a voice.

Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.

Why we shouldn’t forget gelatin’s longstanding reputation as a reliable and trusted excipient.

Why are we still making life difficult for a growing patient population when solutions exist?

Gene encounters some challenges with chromatographic performance.

First-of-its-kind Parkinson’s trial, Brexit woes, and a vaccine scandal in China… What’s new for pharma in business?

A robotic arm takes mass spec analysis of 3D objects to the next level.

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.